ID: ALA3901175

Max Phase: Preclinical

Molecular Formula: C19H21BrN2O2

Molecular Weight: 389.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(C(=O)Nc1ccc(C2CCNC2)cc1)c1ccc(Br)cc1

Standard InChI:  InChI=1S/C19H21BrN2O2/c1-24-18(14-2-6-16(20)7-3-14)19(23)22-17-8-4-13(5-9-17)15-10-11-21-12-15/h2-9,15,18,21H,10-12H2,1H3,(H,22,23)

Standard InChI Key:  HGTDOUKPOOCPSE-UHFFFAOYSA-N

Associated Targets(non-human)

Trace amine-associated receptor 1 899 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.29Molecular Weight (Monoisotopic): 388.0786AlogP: 3.85#Rotatable Bonds: 5
Polar Surface Area: 50.36Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.86CX Basic pKa: 10.96CX LogP: 3.39CX LogD: 0.41
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.82Np Likeness Score: -0.82

References

1.  (2016)  Substituted benzamides, 

Source

Source(1):